GSK-CureVac's 2nd Covid vaccine shows better immune response
CV2CoV has higher neutralising capacity against a range of variants, including the Beta, Delta and Lambda variant and the original virus strain, the company said in a statement on Monday.
Aug 17, 2021, 16:33 PM IST